Certified by Founder
Lodge
Sift Biosciences
start up
United States
- San Carlos, CA
- 19/02/2026
- Pre-Seed
- $3,700,000
Using AI and high-throughput T-cell screening, Sift is developing a new class of T-cell modulators to treat cancers and autoimmune diseases.
- Industry Biotechnology Research
- Website https://siftbio.com/
- LinkedIn https://www.linkedin.com/company/sift-biosciences/
Related People
Yue Clare Lou, Ph.D.Co Founder
United States -
San Francisco Bay Area
Scientist | Founder
Immunology | Cancer <> AI/Bioinformatics <> Microbiology
Forage | $40,000,000 | (Jun 5, 2026)
InCharge Energy | $46,000,000 | (Jun 5, 2026)
Oak Hill Bio | $32,500,000 | (Jun 5, 2026)
ZutaCore | $100,000,000 | (Jun 5, 2026)
Terra AI | $20,000,000 | (Jun 5, 2026)
Town | $55,000,000 | (Jun 5, 2026)
Lassie | $35,000,000 | (Jun 5, 2026)
OFFROAD | $7,000,000 | (Jun 5, 2026)
Shifters | $10,200,000 | (Jun 5, 2026)
Quobly | $133,545,475 | (Jun 5, 2026)
Scispot | $8,000,000 | (Jun 5, 2026)
Scotch | $20,000,000 | (Jun 5, 2026)